Facebook
Twitter
LinkedIn
ForwardPulse: Rely on Me: Relizorb vs. Oral Pancreatic Enzymes for Exocrine Pancreatic Insufficiency_enduring
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pancreatic enzyme replacement therapy (PERT) is key to the prevention of malnutrition in patients with exocrine pancreatic insufficiency. While the American Gastroenterological Association guidelines list both oral pancreatic enzymes and immobilized lipase (Relizorb) as potential therapeutic options, they do not indicate a preference for either agent. This presentation will introduce pharmacists to important efficacy and safety considerations for choosing and dispensing PERT.
Target Audience
Pharmacist
Learning Objectives
1. Describe current treatment approaches for pancreatic enzyme supplementation in patients with exocrine pancreatic insufficiency.
2. Identify patient safety concerns associated with administration of oral pancreatic enzymes via feeding tube.
3. Discuss key study outcomes comparing the efficacy of oral pancreatic enzymes versus immobilized lipase (Relizorb).
Additional Information
| Attachment | Size |
|---|---|
 Disclosure Slides_Rogers.pdf | 283.58 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pancreatic enzyme replacement therapy (PERT) is key to the prevention of malnutrition in patients with exocrine pancreatic insufficiency. While the American Gastroenterological Association guidelines list both oral pancreatic enzymes and immobilized lipase (Relizorb) as potential therapeutic options, they do not indicate a preference for either agent. This presentation will introduce pharmacists to important efficacy and safety considerations for choosing and dispensing PERT.
Tara Rogers, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.